April 01, 2019
Fusion Pharmaceuticals Raises $105 Million In Oversubscribed Series B Financing
Media
April 01, 2019
Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update
March 29, 2019
District Court of Delaware rules that Actavis does not infringes with their Suboxone® and Subutex® generics
March 29, 2019
MIPS AB today publishes the 2018 Annual Report
March 25, 2019
Strongbridge Biopharma plc Announces Presentation of New Data Analyses from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Potential Treatment of Endogenous Cushing’s Syndrome
March 21, 2019
MIPS unable to replicate new WaveCel helmet technology performance claims
March 21, 2019
Orexo publishes the Annual Report for 2018
March 21, 2019
MIPS comments communication from Bontrager regarding new technology in some of its helmet models
March 20, 2019
Pfizer secures exclusive option to acquire gene therapy company Vivet Therapeutics
March 19, 2019
Altimmune Announces Positive Results from NasoVAX Extension Study
